Results 71 to 80 of about 1,651 (200)
Radiopharmaceuticals enable precise cancer diagnosis and targeted therapy by combining radioactive isotopes with carrier molecules. This review summarizes advances from 2014 to 2025, emphasizing probe design, click chemistry, novel targets, and nanodelivery systems.
Mohd Sayeed Shaikh +7 more
wiley +1 more source
Background Prostate cancer is a common cancer among men worldwide that has a very poor prognosis, especially when it progresses to metastatic castration-resistant prostate cancer (mCRPC).
Hiroyuki Suzuki +8 more
doaj +1 more source
Multifunctional Clickable Reagents for Rapid Bioorthogonal Astatination and Radio-Crosslinking [PDF]
In the past decade, several developments have expanded the chemical toolbox for astatination and the preparation of 211 At-labeled radiopharmaceuticals.
Aneheim, Emma +6 more
core +1 more source
Process for producing astatine-211 for radiopharmaceutical use
A process for reliably and consistently producing astatine-211 in small controlled volumes of a solution, which is selected from a choice of solvents that are useful in selected radiopharmaceutical procedures in which the At-211 activities are to be applied.
Saed Mirzadeh, Richard M. Lambrecht
openaire +1 more source
ABSTRACT Exercise testing has long been essential for evaluating diagnosis, prognosis, and functional status in pulmonary hypertension (PH). Recent advances have clarified its role in defining reference values and prognostic markers. Nonetheless, substantial knowledge gaps persist regarding the implementation of invasive cardiopulmonary exercise ...
Aaron B. Waxman +20 more
wiley +1 more source
Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximab [PDF]
This study demonstrates high-efficiency sterilisation of single cancer cells in a SCID mouse model of leukaemia using rituximab, a monoclonal antibody that targets CD20, labelled with terbium-149, an alpha-emitting radionuclide.
Beyer, G.-J +8 more
core
SPECT assay of radiolabeled monoclonal antibodies. Final performance report, March 1992--November 1995 [PDF]
Research is described in the following areas: development and evaluation quantitatively of reconstruction algorithms with improved compensations for attenuation, scatter, and geometric collimator response; evaluation of single photon emission computed ...
Jaszczak, R.J.
core +1 more source
Production and Distillation of the Therapeutic Radionuclide Astatine-211 at the Texas A&M Cyclotron Institute [PDF]
The use of the alpha particle emitting radionuclide ²¹¹At for clinical therapy of primary and metastatic tumors via targeted methods is an attractive modality for increasing cancer management and survivability.
Martin, Thomas Michael
core +3 more sources
Evaluation of a Wet Chemistry Method for Isolation of Cyclotron Produced [211At]Astatine
A “wet chemistry” approach for isolation of 211At from an irradiated bismuth target is described. The approach involves five steps: (1) dissolution of bismuth target in conc.
Shigeki Watanabe +6 more
doaj +1 more source

